Celltrion Pharm Reports Q1 Operating Profit of 9.5 Billion KRW, Up 23% YoY

Celltrion Pharm announced on the 12th that its operating profit on a separate basis for the first quarter of this year was 9.55 billion KRW, an increase of 23.1% compared to the same period last year.

Sales amounted to 90.01 billion KRW, up 1.4% from the same period last year. A Celltrion Pharm official said, "This quarter, major products in the chemical and biopharmaceutical sectors posted solid sales, showing a stable growth trend."